Clinical trial
A Study to Evaluate the Effectiveness and Safety of Multiple Applications of…
NCT00189267 · MEDA Pharma GmbH & Co. KG, Industry · Completed
Key facts
| NCT number | NCT00189267 |
|---|---|
| Title | A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients |
| Official title | Vehicle-Controlled, Double-Blind Study to Assess the Safety and Efficacy of Imiquimod 5% Cream Applied Once Daily 3 Days Per Week for the Treatment of Actinic Keratoses in Immunosuppressed Organ Transplant Recipients. |
| Lead sponsor | MEDA Pharma GmbH & Co. KG, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Actinic Keratosis |
| Intervention type | Drug |
| Interventions | Imiquimod 5 % Cream |
| Enrollment | 45 |
| Start date | Nov 1, 2002 |
| Completion | Sep 1, 2005 |
| First posted | Sep 19, 2005 |
| Last update posted | Feb 7, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: